• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Perioperative statin use may reduce complications and mortality in non-cardiac surgery

byShayna BejaimalandAnees Daud
December 20, 2016
in Cardiology, Public Health, Surgery
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In this propensity-matched retrospective cohort study, perioperative statin use was associated with reduced risk of 30-day mortality and risk of postoperative complications.

2. Sub-analyses indicated that patients with pre-existing ischemic heart disease, diabetes, age <75 years old, high risk surgery and use of high-intensity statin therapy may have the greatest benefit.

Evidence Rating Level: 2 (Good)

Study Rundown: Statins are one of the most frequently prescribed drugs in America because of their role in reducing cardiovascular events. Their use in reducing perioperative risk of complications or mortality, however, is unclear. This retrospective cohort study aimed to evaluate the association of early statin exposure on 30-day mortality and complications after non-cardiac surgery.

In this predominantly male, propensity-matched cohort, exposure to a statin on the day before or the day of non-cardiac surgery was associated with a reduction in 30-day all-cause mortality, with a corresponding number needed to treat of 244. There was also a reduction in risk of any post-operative complications, with a number needed to treat of 67. The greatest risk reduction was seen with cardiac complications. Strengths of the study included the large size of the cohort and the propensity-match design. Limitations included the predominance of males in the studied cohort, and reliance on medical records. Also, the effects of the type of statin and duration of treatment prior to surgery date were not studied.

Click to read the study, published today in JAMA Internal Medicine

Relevant Reading: Preoperative statin therapy for patients undergoing cardiac surgery

RELATED REPORTS

Tranexamic acid decreases postoperative bleeding in non-cardiac surgery patients

Systematic review and meta-analysis of statin-induced reduction in LDL-C demonstrates modest absolute benefits

Statin therapy initiation is associated with diabetes progression

In-Depth [retrospective cohort study]: This retrospective cohort was derived from the Veterans Affairs Surgical Quality Improvement Program database and discharge and treatment coding from the Veterans Health Administration patient treatment files from 2005 to 2010. These treatment files also included data on medications used. Patients included were those undergoing elective or emergent non-cardiac surgery (vascular, general, neurosurgery, orthopedic, thoracic, urologic, otolaryngologic). The exposure of interest was statin use on the day of or day after surgery and the primary outcome of interest was all-cause 30-day mortality and secondary outcomes included cardiovascular and non-cardiovascular complications. Statistical analysis included propensity score matching (1:1) to match patients with statin exposure and no exposure as well as the McNemar test and calculated relative risk ratios to compare risk of the primary and secondary outcomes between groups.

The propensity-score matched cohort included 96 486 eligible patients, 96.3% of whom were men. At the time of admission to hospital, 37.8% of patients already had an active prescription for statin. Perioperatively, 31.5% of the cohort had exposure to a statin on the day of or day after surgery. Among the 48 243 propensity-score matched pairs, 30-day all cause mortality was significantly reduced in statin exposed patients (RR 0.82; 95% CI 0.75-0.89; p < 0.001). The number needed to treat was 244 (95% CI 170-432). There was also a significant reduction in risk of any perioperative complication (RR 0.82; 95% CI 0.79-0.86; p < 0.001). The number needed to treat was 67 (95% CI 55-87). Greatest risk reduction was seen for cardiac complications (RR 0.73; 95% CI 0.64-0.83). Sub-analyses indicate that patients with pre-existing ischemic heart disease, diabetes, those <75 years old, those undergoing high risk surgery and those on intensive high dose statin therapy may have greatest risk reduction with perioperative statin treatment.

Image: PD

©2016 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: perioperativestatins
Previous Post

2 Minute Medicine Rewind December 19, 2016

Next Post

Hidradenitis suppurativa associated with increased risk of subclinical atherosclerosis

RelatedReports

Preoperative tumor embolization does not reduce operative blood loss
Cardiology

Tranexamic acid decreases postoperative bleeding in non-cardiac surgery patients

June 18, 2022
Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription
Cardiology

Systematic review and meta-analysis of statin-induced reduction in LDL-C demonstrates modest absolute benefits

April 7, 2022
Quick Take: The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomized trial
Cardiology

Statin therapy initiation is associated with diabetes progression

October 8, 2021
Cardiology

Preoperatively diagnosed patent foramen ovale linked to increased perioperative stroke risk

February 8, 2018
Next Post
Hidradenitis suppurativa associated with increased risk of subclinical atherosclerosis

Hidradenitis suppurativa associated with increased risk of subclinical atherosclerosis

Computed tomography improves diagnostic certainty in the emergency department

Medicaid expansion under Affordable Care Act associated with increased hospital choice

No association found between length of storage for transfused red blood cells and patient mortality

No association found between length of storage for transfused red blood cells and patient mortality

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Subthreshold micropulse laser is equivalent to standard laser for treating diabetic macular edema
  • Gadolinium-containing contrast associated with nephrogenic fibrosing dermopathy and systemic fibrosis [Classics Series]
  • Study supports continued use of amoxicillin as first-line therapy for pediatric ear infections
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.